Invesco Biotechnology & Genome ETF
PBE
PBE
71 hedge funds and large institutions have $75.4M invested in Invesco Biotechnology & Genome ETF in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
19% less capital invested
Capital invested by funds: $93.2M → $75.4M (-$17.8M)
Holders
71
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.61M | |
| 2 | +$2.44M | |
| 3 | +$1.74M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.61M |
| 5 |
PA
PFG Advisors
Phoenix,
Arizona
|
+$1.6M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$2.04M | |
| 3 | -$452K | |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$415K |
| 5 |
EA
Evanston Advisors
Schaumburg,
Illinois
|
-$238K |